Skip to main content
. 2016 Jul 25;11(7):e0158037. doi: 10.1371/journal.pone.0158037

Fig 1. Short term HAART has no effect on the progression of chronic liver disease in HIV/HCV Co-infection group.

Fig 1

A) The degree of liver fibrosis (Group HIV/HCVc (n = 21) vs Group HIVt/HCVc (n = 19) B) ALB/GLB ratio (Group HIV/HCVc (n = 25) vs Group HIVt/HCVc (n = 43) and C) HCV virus load (Group HIV/HCVc (n = 29) vs Group HIVt/HCVc (n = 42) were compared between subgroups of HIV/HCV co-infected treatment naive group and HIV/HCV co-infected group that received short term HAART. The p values calculated by Mann-Whitney U test. Data are presented as median with interquartile range.